applications > All applications
234
Real-time fluorescence assay for monitoring transglutaminase activity

Magdalena Adamczyk, Andreas Heil, Daniel Aeschlimann, Matrix Biology & Tissue Repair Research Unit, School of Dentistry, Cardiff University, Heath Park, Cardiff, CF14 4XY, UK, 04/2013

  • Isopeptidase assay for kinetic analysis of transglutaminase activity
  • Optimized protocols for FLUOstar OPTIMA and Omega allow for
    rapid implementation and standardization of measurements
  • Assay is amenable to high throughput analysis of regulators/inhibitors
    of catalysis

Request more information

Introduction

Transglutaminases (TGs) form a family of enzymes that catalyze various posttranslational protein modifications such as crosslinking, esterification and deamidation in a Ca2+-dependent manner.(1) Their main function is the formation of covalent Nε-(γ-glutamyl)lysine bonds within or between polypeptides to stabilize protein assemblies. The activity of these enzymes is crucial for tissue homeostasis and function in a number of organ systems, and the lack of or the excessive crosslinking activity have been linked to human disease processes(1,2).

Here we perform kinetic measurements using recombinant TG2 and a fluorescent peptide model substrate on a FLUOstar OPTIMA and FLUOstar Omega in a format suitable for high-throughput analysis. This assay principle can be applied to kinetic studies on closely related enzymes including TG6(3) and can be optimised by modification of the backbone peptide sequence.

Assay Principle

 


Fig. 1a: Structure of quenched substrate Abz-APE(γ-cad-Dnp)QEA whereby 2-aminobenzoyl (Abz) and
2,4-dinitrophenyl (Dnp) are fluorescent donor and quenching acceptor group, respectively.

The TG enzymatic reaction is a two-step process. The thioester intermediate of the enzyme formed with the substrate in the first step subsequently reacts with a nucleophile to regenerate active enzyme and release a ‘crosslinked’ polypeptide. The second step is reversible and, in the presence of an excess of crosslinked substrate, TG catalyzes isopeptide bond hydrolysis(4). We have exploited this latter activity for real-time monitoring of TG activity and characterize the effect of potential regulators on TG activity.

 

Fig. 1b: Reaction scheme for TG catalyzed isopeptidase reaction with substrate Abz-APE(γ-cad-Dnp)QEA in the presence of an excess of unlabeled primary amine (R4-NH2, e.g. glycine methylester). R: Abz-AP; R2: QEA; R3: (CH2)4-NH-Dnp; E-SH (TG2 with active site thiol group).

 

Abz-APE(γ-cad-Dnp)QEA is a quenched fluorescent probe derived from a known glutamine donor substrate(5) that mimics a crosslinked TG reaction product. In this peptide the fluorophore (2-aminobenzoyl (Abz)) is quenched by a 2,4-dinitrophenyl-cadaverine (cad-Dnp) substituent on the first Gln residue, essentially replacing the Lys side chain in Nε-(γ-glutamyl)lysine linked peptides (Fig. 1A). TG2-catalysed hydrolysis of the isopeptide bond releases the cad-Dnp moiety (Fig. 1B) and consequently generates an increase in light emission at λmax=418 nm from the Abz group. The thioester enzyme intermediate formed is subsequently deacylated through either aminolysis or hydrolysis. Specificity of the reaction is guided by the amino acid residues that surround the reactive Gln residue(3).

Materials and Methods

  • FLUOstar OPTIMA or FLUOstar Omega (Fig. 3) microplate readers from BMG LABTECH
  • Black optical bottom 96-well plates (165305, Nunc)
  • Abz-APE(γ-cad-Dnp)QEA TG2 substrate (A102; Zedira, Darmstadt, Germany). 50 mM stock in DMSO
  • Transglutaminase 2(6), 1 mg/ml stock, cleared by centrifugation at 14,000 x g for 30 min at 4°C and concentration derived from OD280 using ε = 1352 cm2/g; keep on ice and prevent repeated freeze-thawing (similar high quality product is available from Zedira: T002)

Assay buffer
The assay buffer consists of 62.5 mM Tris/HCl, pH 7.4, 125 mM NaCl. Add glycine methylester (or alternative amine donor substrate) and adjust pH immediately before use (at 37°C). Include DTT to prevent oxidative inactivation of TG.

Test protocol
Prime the FLUOstar injectors with 20 mM CaCl2 for enzyme activation (inj. 1) and H2O or 20 mM MgCl2 for control reaction (inj. 2). Pre-warm assay buffer and plate to 37°C and equilibrate instrument chamber at 37°C. Dilute substrate Abz-APE(γ-cad-Dnp)QEA (1:800) in assay buffer and add 80 µl of mixture into wells of the 96-well plate. Add desired amount of enzyme, e.g. 1 µg of TG2, and make up volume with H2O to 90 µl. Transfer plate immediately into the reader and start program.

Reaction mixture (final concentrations)
The final assay volume is 100 µl and consists of 1-100 µg/ml TG2, 50 µM Abz-APE(γ-cad-Dnp)QEA, 10-55 mM glycine methylester or alternative nucleophile, as well as 1-5 mM DTT. After injection there is 2 mM CaCl2 present in samples.

Instrument settings
Mode: Fluorescence Intensity, plate mode
Filters: Ex320 for excitation and 440-10 for emission
Optics top
No. of flashes: 20
Cycles: 90
Cycle time: 40 s (for 12 wells)
Injection cycle: 10
Injection volume: 10 µL
Shaking: 5 s after each cycle
Temperature: 37°C

Results and Discussion

After Ca2+ injection an increase in fluorescence can be observed dependent on the concentration of enzyme in sample (Fig. 2).

Fig. 2: Raw data (A) and processed data (B) of substrate Abz-APE(γ-cad-Dnp)QEA conversion at different concentrations of TG2 (2.5 – 20 µg/ml) as measured with Optima instrument. Control given represents 20 µg/ml TG2 without Ca2+ injection. Data processing involved normalization for well-specific fluorescence and subtraction of control to account for fluorescence bleaching. C: Reaction rate is linearly correlated to enzyme concentration (orange, Optima data; green, Omega data). D: Allosteric regulation of TG2 by nucleotides. Isopeptidase activity of TG2 measured in the presence of different concentrations of nucleotides: GTP, red line; GTPγS, yellow line; and ATP, blue line.

TG2-mediated substrate conversion is linear for >30 min and initial reaction rates can be derived from linear regression of first 15-25 data points (Fig. 2A and B). Fluorescence emission of the standard peptide Abz-APQQEA was found to correlate linearly with concentration for 0.13-2.0 µM (gain 2450) on the FLUOstar OPTIMA and 0.016-0.5 µM (gain 2450) or 0.03-2.0 µM (gain 1883) on the FLUOstar Omega (Fig. 2C). Enzymatic conversion of Abz-APE(γ-cad-Dnp)QEA was measureable down to 1 µg/ml (~13 nM) for TG2 on the FLUOstar OPTIMA.

The plate format is ideal for investigating the effect of potential regulators or inhibitors on catalysis. GTP is a well characterized allosteric regulator of TG2(7). Using the outlined reaction conditions and 20 µg/ml TG2 and different concentrations of nucleotides, we have determined IC50 concentrations of 2.9 µM, 3.6 µM, and ~1 mM for GTP, GTPγS and ATP, respectively, which is in good agreement with data in the literature (Fig. 2D).

Conclusion


Fig. 3: BMG LABTECH’s FLUOstar Omega multidetection microplate reader

Reported here are optimized experimental conditions for determination of TG2 isopeptidase activity with the fluorescent model substrate Abz-APE(γcad-Dnp)QEA using the FLUOstar OPTIMA/Omega plate readers to produce an assay that is rapid, direct and sensitive. Automated injection of Ca2+ for enzyme activation combined with the ability to continuously measure fluorescence intensity over a considerable time period with limited photobleaching facilitates the acquisition of kinetic data. Small sample size and plate format make the assay cost-effective and adaptable to high-throughput analysis.

Acknowledgements

This work was supported by grants from Coeliac UK and Arthritis Research UK (18461), and PhD studentships from Cardiff University/the President’s Scholarship scheme to MA and AH.

References

  1. Aeschlimann D, Thomazy, V. (2000). Connect Tissue Res. 41:1-27.
  2. Iismaa, S, et al., (2009). Physiol. Rev. 89:991-1023.
  3. Thomas H, et al., (2013). Amino Acids. 44: 161-177.
  4. Parameswaran, KN, et al., (1997). J. Biol. Chem. 272:10311-10317.
  5. Hohenadl C, et al., (1995). J. Biol. Chem. 270: 23415-23420.
  6. Hadjivassiliou M, et al., (2008). Ann. Neurol. 64:332-343.
  7. Lui S, et al., (2002). Proc. Natl. Acad. Sci. USA. 99: 2743-2747.